Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
!!T3 BUPIVACAINE INJECTION BP | STERIMAX INC | Actual shortage | 2.5MG | Updated Report | 2024-05-16 | 213678 |
!!T3 BUPIVACAINE INJECTION BP | STERIMAX INC | Actual shortage | 2.5MG | Updated Report | 2024-05-16 | 213681 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 20MG | Updated Report | 2024-05-16 | 225521 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 10MG | Updated Report | 2024-05-16 | 225515 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 50MG | Updated Report | 2024-05-16 | 217783 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 100MG | Updated Report | 2024-05-16 | 216254 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 25MG | Updated Report | 2024-05-16 | 216264 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 10MG | Updated Report | 2024-05-16 | 225518 |
VENLAFAXINE XR | SANIS HEALTH INC | Actual shortage | 37.5MG | Updated Report | 2024-05-16 | 225878 |
RISPERIDONE | SANIS HEALTH INC | Actual shortage | 0.25MG | Updated Report | 2024-05-16 | 223270 |
GABAPENTIN | SANIS HEALTH INC | Actual shortage | 400MG | Updated Report | 2024-05-16 | 223259 |
FLUOXETINE | SANIS HEALTH INC | Actual shortage | 20MG | Updated Report | 2024-05-16 | 164466 |
FLUOXETINE | SANIS HEALTH INC | Actual shortage | 20MG | Updated Report | 2024-05-16 | 164462 |
OCUFLOX | ABBVIE CORPORATION | Actual shortage | 0.3% | Updated Report | 2024-05-16 | 217532 |
ALFUZOSIN | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-16 | 223485 |
FLUOXETINE | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-16 | 164459 |
SOLU-MEDROL | PFIZER CANADA ULC | Actual shortage | 1G | Updated Report | 2024-05-16 | 220618 |
PROZAC CAPSULES 10MG | ELI LILLY CANADA INC | Actual shortage | 10MG | Updated Report | 2024-05-16 | 220045 |
PENICILLIN G SODIUM FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 10000000UNIT | Updated Report | 2024-05-16 | 226550 |
MULTI 12 INJECTION | SANDOZ CANADA INCORPORATED | Actual shortage | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Updated Report | 2024-05-16 | 217399 |
MYOVIEW 30ML | GE HEALTHCARE CANADA INC | Resolved | 1.38MG | Updated Report | 2024-05-16 | 226858 |
IRINOTECAN HYDROCHLORIDE INJECTION USP | ACCORD HEALTHCARE INC | Actual shortage | 20MG | Updated Report | 2024-05-16 | 223399 |
GD-DICLOFENAC/MISOPROSTOL 75 | GENMED A DIVISION OF PFIZER CANADA ULC | Actual shortage | 200MCG 75MG | Updated Report | 2024-05-16 | 227003 |
CANDESARTAN-HCTZ | PRO DOC LIMITEE | Resolved | 12.5MG 16.0MG | Updated Report | 2024-05-16 | 227037 |
AMPICILLIN FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 250MG | Updated Report | 2024-05-16 | 226471 |
LODALIS | BAUSCH HEALTH, CANADA INC. | Actual shortage | 625MG | Updated Report | 2024-05-15 | 226788 |
GD-DICLOFENAC/MISOPROSTOL 50 | GENMED A DIVISION OF PFIZER CANADA ULC | Anticipated shortage | 200MCG 50MG | Updated Report | 2024-05-15 | 220932 |
APO-WARFARIN | APOTEX INC | Resolved | 1MG | Updated Report | 2024-05-15 | 225782 |
APO-WARFARIN | APOTEX INC | Resolved | 1MG | Updated Report | 2024-05-15 | 224589 |
METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Anticipated shortage | 25MG | New Report | 2024-05-15 | 228024 |
MYLAN-TOPIRAMATE | MYLAN PHARMACEUTICALS ULC | Resolved | 100MG | Updated Report | 2024-05-15 | 224061 |
MYLAN-VALACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Resolved | 500MG | Updated Report | 2024-05-15 | 223279 |
MYLAN-VALACYCLOVIR | MYLAN PHARMACEUTICALS ULC | Resolved | 1000MG | Updated Report | 2024-05-15 | 207184 |
LMD 10% IN DEXTROSE 5% | PFIZER CANADA ULC | Actual shortage | 5% 10% | Updated Report | 2024-05-15 | 213206 |
BENZTROPINE OMEGA | OMEGA LABORATORIES LIMITED | Actual shortage | 1MG | New Report | 2024-05-15 | 228008 |
POTASSIUM ACETATE INJECTION USP | OMEGA LABORATORIES LIMITED | Resolved | 39.2% | Updated Report | 2024-05-15 | 213117 |
POSANOL | MERCK CANADA INC | Actual shortage | 100MG | Updated Report | 2024-05-15 | 222593 |
CATHFLO | HOFFMANN-LA ROCHE LIMITED | Anticipated shortage | 2MG | Updated Report | 2024-05-15 | 227997 |
PROQUAD | MERCK CANADA INC | Anticipated shortage | 3.99Log10 PFU 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50 | Updated Report | 2024-05-15 | 221447 |
RENVELA | SANOFI-AVENTIS CANADA INC | Resolved | 800MG | Updated Report | 2024-05-15 | 219863 |
CAVERJECT STERILE POWDER | PFIZER CANADA ULC | Resolved | 20MCG | Updated Report | 2024-05-15 | 154018 |
CARBETOCIN INJECTION | JUNO PHARMACEUTICALS CORP. | Resolved | 100MCG | Updated Report | 2024-05-15 | 206942 |
M-M-R II | MERCK CANADA INC | Resolved | 1000UNIT 5000UNIT 1000UNIT | Updated Report | 2024-05-15 | 221457 |
ARTHROTEC 75 | PFIZER CANADA ULC | Anticipated shortage | 200MCG 75MG | Updated Report | 2024-05-14 | 227000 |
ENSPRYNG | HOFFMANN-LA ROCHE LIMITED | Avoided shortage | 120MG | Updated Report | 2024-05-14 | 227132 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Actual shortage | 30MG | Updated Report | 2024-05-14 | 166975 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Actual shortage | 20MG | Updated Report | 2024-05-14 | 166972 |
OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2024-05-14 | 166969 |
TEVA-TOPIRAMATE | TEVA CANADA LIMITED | Actual shortage | 25MG | Updated Report | 2024-05-14 | 224889 |
TEVA-OMEPRAZOLE | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2024-05-14 | 217231 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
EYE STREAM | ALCON CANADA INC | Discontinued | 0.03% 0.048% 0.075% 0.64% | New Report | 2024-05-15 | 228021 |
MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN PHARMACEUTICALS ULC | Discontinued | 0.4MG | New Report | 2024-05-08 | 227338 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG 0.5MG | New Report | 2024-05-03 | 227052 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG | New Report | 2024-05-03 | 227049 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 0.5MG | New Report | 2024-05-03 | 227046 |
AUBAGIO | SANOFI-AVENTIS CANADA INC | To be discontinued | 14MG | New Report | 2024-05-02 | 226847 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226748 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226753 |
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-05-02 | 224344 |
SANDOZ D 10 000 | SANDOZ CANADA INCORPORATED | Discontinued | 10000UNIT | Updated Report | 2024-05-02 | 226738 |